Drozd, Chloé
Curtit, Elsa
Jacquinot, Quentin
Marquine, Charlène
Mansi, Laura
Chaigneau, Loïc
Dobi, Erion
Viot, Julien
Meynard, Guillaume
Paillard, Marie-Justine
Goujon, Morgan
Roux, Pauline
Vernerey, Dewi
Gillet, Valérie
Bourdin, Hubert
Galli, Silvio
Meneveau, Nathalie
Mougin, Fabienne
Article History
Received: 11 April 2023
Accepted: 28 April 2023
First Online: 17 May 2023
Declarations
:
: The FATSOMCAN study was approved by the Ethics Committee “Comité de Protection des Personnes Ouest III” on 15/09/2020 under the number 2020-A00511-38, and by the National Health Products Safety Agency (N° IDRCB 2020-A00511-38). This study is registered at the National Clinical Trials (NPSGCT02433067) since 30 April 2021.All participants are fully informed of the experimental procedures and provided written informed consent. All methods are carried out in accordance with relevant guidelines and regulations. The current study is performed in accordance with the Declaration of Helsinki.
: Not applicable.
: The authors declare that the research is conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.